Qilian International Holding Group (BGM) Competitors $11.03 +0.17 (+1.57%) As of 04/24/2025 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock BGM vs. PCVX, RYTM, PTCT, ACLX, RARE, ZLAB, RNA, AKRO, MRUS, and MORShould you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include Vaxcyte (PCVX), Rhythm Pharmaceuticals (RYTM), PTC Therapeutics (PTCT), Arcellx (ACLX), Ultragenyx Pharmaceutical (RARE), Zai Lab (ZLAB), Avidity Biosciences (RNA), Akero Therapeutics (AKRO), Merus (MRUS), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry. Qilian International Holding Group vs. Vaxcyte Rhythm Pharmaceuticals PTC Therapeutics Arcellx Ultragenyx Pharmaceutical Zai Lab Avidity Biosciences Akero Therapeutics Merus MorphoSys Vaxcyte (NASDAQ:PCVX) and Qilian International Holding Group (NASDAQ:BGM) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk. Is PCVX or BGM more profitable? Qilian International Holding Group's return on equity of 0.00% beat Vaxcyte's return on equity.Company Net Margins Return on Equity Return on Assets VaxcyteN/A -23.53% -22.20% Qilian International Holding Group N/A N/A N/A Which has more risk & volatility, PCVX or BGM? Vaxcyte has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Does the media favor PCVX or BGM? In the previous week, Vaxcyte had 19 more articles in the media than Qilian International Holding Group. MarketBeat recorded 20 mentions for Vaxcyte and 1 mentions for Qilian International Holding Group. Vaxcyte's average media sentiment score of 1.01 beat Qilian International Holding Group's score of 0.00 indicating that Vaxcyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vaxcyte 9 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Qilian International Holding Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, PCVX or BGM? Qilian International Holding Group has higher revenue and earnings than Vaxcyte. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaxcyteN/AN/A-$402.27M-$3.80-9.08Qilian International Holding Group$25.10M42.73-$1.44MN/AN/A Does the MarketBeat Community prefer PCVX or BGM? Vaxcyte received 55 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformVaxcyteOutperform Votes5578.57% Underperform Votes1521.43% Qilian International Holding GroupN/AN/A Do analysts rate PCVX or BGM? Vaxcyte currently has a consensus price target of $136.50, suggesting a potential upside of 295.54%. Given Vaxcyte's stronger consensus rating and higher possible upside, equities research analysts plainly believe Vaxcyte is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaxcyte 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in PCVX or BGM? 96.8% of Vaxcyte shares are held by institutional investors. 3.1% of Vaxcyte shares are held by insiders. Comparatively, 58.7% of Qilian International Holding Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryVaxcyte beats Qilian International Holding Group on 8 of the 14 factors compared between the two stocks. Get Qilian International Holding Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07B$6.59B$5.41B$7.70BDividend YieldN/A3.21%5.44%4.33%P/E RatioN/A7.0522.2318.31Price / Sales42.73273.45398.02107.04Price / CashN/A65.6738.2034.62Price / Book1.816.506.824.25Net Income-$1.44M$142.50M$3.20B$247.51M7 Day Performance-1.17%8.32%5.78%6.86%1 Month Performance-0.72%-5.61%-4.31%-2.95%1 Year PerformanceN/A0.11%17.88%5.17% Qilian International Holding Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMQilian International Holding GroupN/A$11.03+1.6%N/AN/A$1.07B$25.10M0.00298Positive NewsPCVXVaxcyte3.2792 of 5 stars$30.39-0.8%$136.50+349.2%-42.8%$3.91BN/A-6.61160Analyst ForecastAnalyst RevisionPositive NewsRYTMRhythm Pharmaceuticals3.8928 of 5 stars$60.48-2.0%$74.92+23.9%+58.6%$3.82B$130.13M-13.97140Positive NewsPTCTPTC Therapeutics3.8715 of 5 stars$48.19+1.7%$63.77+32.3%+96.5%$3.80B$806.78M-8.111,410Analyst ForecastInsider TradeACLXArcellx1.9066 of 5 stars$60.93-1.8%$110.67+81.6%+21.1%$3.35B$107.94M-85.8280News CoveragePositive NewsRAREUltragenyx Pharmaceutical4.456 of 5 stars$35.40-0.8%$92.79+162.1%-15.0%$3.32B$560.23M-5.581,310Upcoming EarningsZLABZai Lab2.8676 of 5 stars$29.71+3.0%$47.37+59.4%+115.8%$3.26B$398.99M-10.731,950Analyst RevisionGap UpRNAAvidity Biosciences2.3623 of 5 stars$28.52+7.0%$66.69+133.8%+23.3%$3.20B$10.90M-9.90190Positive NewsAKROAkero Therapeutics4.1786 of 5 stars$37.67+0.1%$76.29+102.5%+102.3%$3.00BN/A-10.0530Positive NewsGap UpMRUSMerus3.1559 of 5 stars$43.23+0.4%$85.31+97.3%+5.7%$2.99B$36.13M-10.9437Positive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730 Related Companies and Tools Related Companies PCVX Competitors RYTM Competitors PTCT Competitors ACLX Competitors RARE Competitors ZLAB Competitors RNA Competitors AKRO Competitors MRUS Competitors MOR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qilian International Holding Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Qilian International Holding Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
